Sonic Hedgehog Agonists Induce Repair Schwann Cells

Area of Science:

• Neuroscience
• Regenerative Medicine
• Cell Biology

Background:

• Peripheral nerve regeneration is crucial for functional recovery after injury.
• Schwann cells (SCs) play a vital role in supporting axonal regrowth.
• The repair phenotype of SCs is regulated by the transcription factor c-Jun.

Purpose of the Study:

• To identify drugs that promote the SC repair phenotype.
• To investigate the efficacy of Sonic Hedgehog (SHH) agonists, Purmorphamine (PUR) and Smoothened agonist (SAG), in promoting nerve regeneration.
• To determine the optimal dosage of PUR for in vitro applications.

Main Methods:

• Treatment of rat primary SCs with SHH agonists (PUR and SAG).
• Assessment of c-Jun expression, morphological changes, and neurotrophic factor secretion in SCs.
• Coculturing of SCs with dorsal root ganglion (DRG) neurons to evaluate neurite elongation.

Main Results:

• SHH agonists significantly increased c-Jun expression in SCs.
• PUR demonstrated greater potency than SAG in inducing SC repair phenotype.
• PUR at 2.5 µM effectively promoted SC repair characteristics in vitro.
• PUR-treated SCs enhanced neurite elongation in cocultured DRG neurons.

Conclusions:

• SHH agonists, particularly PUR, can effectively reprogram SCs into a pro-regenerative state.
• PUR shows therapeutic potential for enhancing peripheral nerve regeneration and functional recovery.
• Targeting SCs with SHH agonists represents a promising strategy for treating peripheral nerve injuries.